Xencor: Q2 Earnings Snapshot
PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Thursday reported a loss of $22 million in its second quarter.
On a per-share basis, the Pasadena, California-based company said it had a loss of 37 cents.
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 91 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $45.5 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $20.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR
